title: Radiation recall reaction causing cardiotoxicity.
abstract: Radiation recall phenomenon is a tissue reaction that develops within a previously irradiated area, precipitated by the subsequent administration of certain chemotherapeutic agents. It commonly affects the skin, but can also involve internal organs with functional consequences. To our best knowledge, this phenomenon has never been reported as a complication on the heart and should be consider as a potential cause of cardiotoxicity.
authors.affiliation: Department of Medicine, Division of Cardiology, University of Washington, 1959 NE Pacific Street, BOX 356422, Seattle, WA, USA. cmasri@uw.edu.
authors.forename: Sofia Carolina
authors.initials: SC
authors.lastname: Masri
authors.forename: Andrew James
authors.initials: AJ
authors.lastname: Misselt
authors.forename: Arkadiusz
authors.initials: A
authors.lastname: Dudek
authors.forename: Suma H
authors.initials: SH
authors.lastname: Konety
mesh_terms: D000230:Adenocarcinoma / Q000556:secondary / Q000628:therapy*; D000077192:Adenocarcinoma of Lung; D000970:Antineoplastic Agents / Q000009:adverse effects*; D059248:Chemoradiotherapy / Q000009:adverse effects*; D017023:Coronary Angiography; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000628:therapy*; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009205:Myocarditis / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology; D009536:Niacinamide / Q000009:adverse effects / Q000031:analogs & derivatives*; D010671:Phenylurea Compounds / Q000009:adverse effects*; D049268:Positron-Emission Tomography; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011829:Radiation Dosage; D011832:Radiation Injuries / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology; D012307:Risk Factors; D000077157:Sorafenib; D051598:Whole Body Imaging
chemical_list: D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors; D009536:Niacinamide; D000077157:Sorafenib
references.citation: Anticancer Drugs. 2010 Feb;21(2):206-9
references.pmid: 19952730
references.citation: Radiother Oncol. 2001 Jun;59(3):237-45
references.pmid: 11369064
references.citation: Eur Heart J. 2005 Aug;26(15):1461-74
references.pmid: 15831557
references.citation: Radiat Oncol. 2011 Mar 06;6:24
references.pmid: 21375774
references.citation: Ann Oncol. 2000 Dec;11(12):1615-6
references.pmid: 11205473
references.citation: Lancet Oncol. 2008 Feb;9(2):117-23
references.pmid: 18221915
references.citation: Lancet. 1992 Jul 4;340(8810):49
references.pmid: 1351618
references.citation: Cancer Treat Rev. 2005 Nov;31(7):555-70
references.pmid: 16168567